AMG Asset Management Group’s AbbVie ABBV Stock Holding History

AMG Asset Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Buy	4,011 +1	+0%	+$215	0.63%	33
2026 Q1	$872K	Buy	+4,010	New	+$890K	0.68%	31

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AMG Asset Management Group's ABBV Position: Q2 2026 in Review

AMG Asset Management Group increased its AbbVie (ABBV) stake by 0.02% in Q2 2026, buying an estimated $215 and bringing the position to 4,011 shares worth $1.01M. The position accounts for 0.63% of the portfolio, ranked #33.

AMG Asset Management Group first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

AMG Asset Management Group held 4,011 shares of AbbVie worth $1.01M as of Q2 2026.
AMG Asset Management Group bought 1 AbbVie share in Q2 2026, an estimated $215.
AbbVie made up 0.63% of AMG Asset Management Group's portfolio in Q2 2026, its #33 holding.
AMG Asset Management Group first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on AMG Asset Management Group's 13F filing for Q2 2026, filed 29 Jul 2026.